In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Private placement brings 4D pharma £21.5mm

Executive Summary

Four months after completing a £16.6mm IPO, 4D pharma PLC (gut bacteria therapeutics for inflammatory, autoimmune, and GI diseases) raised £21.5mm ($36.6mm) by privately selling 14.3mm shares for £1.50, a 15% discount.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies

UsernamePublicRestriction

Register